Transcend Capital Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,372
| Closed | -$238K | – | 606 |
|
|
2024
Q3 | $238K | Sell |
3,372
-1
| -0% | -$71 | 0.02% | 532 |
|
|
2024
Q2 | $224K | Buy |
3,373
+1
| +0% | +$66 | 0.02% | 529 |
|
|
2024
Q1 | $229K | Hold |
3,372
| – | – | 0.02% | 475 |
|
|
2023
Q4 | $208K | Buy |
+3,372
| New | +$208K | 0.02% | 463 |
|
|
2023
Q3 | – | Sell |
-3,372
| Closed | -$201K | – | 501 |
|
|
2023
Q2 | $201K | Buy |
+3,372
| New | +$201K | 0.02% | 455 |
|
|
2023
Q1 | – | Sell |
-3,372
| Closed | -$209K | – | 504 |
|
|
2022
Q4 | $209K | Buy |
+3,372
| New | +$209K | 0.02% | 441 |
|
|
2022
Q3 | – | Sell |
-3,372
| Closed | -$215K | – | 500 |
|
|
2022
Q2 | $215K | Buy |
3,372
+45
| +1% | +$2.87K | 0.02% | 440 |
|
|
2022
Q1 | $215K | Hold |
3,327
| – | – | 0.02% | 462 |
|
|
2021
Q4 | $221K | Hold |
3,327
| – | – | 0.02% | 438 |
|
|
2021
Q3 | $208K | Hold |
3,327
| – | – | 0.02% | 451 |
|
|
2021
Q2 | $206K | Buy |
+3,327
| New | +$206K | 0.03% | 305 |
|